KZIA Expands Phase 1b Trial of Paxalisib in Advanced Breast Cancer to 36 Patients, Seeks Broader Clinical and Translational Dataset
Kazia Therapeutics Limited American Depositary Shares · PHARMACEUTICAL PREPARATIONS · Now $12.78
-13% in 1d after detection
Post-detection moves
1h
-1.6%
1d
-13%
3d
-8.1%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS